RBOT

$2.01

$

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Beta

1.548

Average Volume

Market Cap

Last Dividend

CIK

0001812173

ISIN

US92561V2088

CUSIP

92561V109

CEO

Stephen From

Sector

Healthcare

Industry

Medical - Devices

Full Time Employees

123

IPO Date

2020-09-04

Status

Active

Latest News

Title Headline Publisher Date
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the successful completion of an in-vivo porcine lab conducted in December 2025, marking a meaningful step forward in the development of the company's robotic system and reinforcing progress toward system design freeze targeted for the end of 2026. During the lab, surgeons independently completed. Business Wire 2026-01-12 08:30:00
RBOT Enters Strategic Software Partnership to Streamline Development Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability. Zacks Investment Research 2025-12-30 11:46:10
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has entered into a strategic partnership agreement with a global digital engineering and software development services firm. This engagement is a central component of the Company's broader operating model transformation, designed to improve execution, increase development predictabil. Business Wire 2025-12-29 16:10:00
NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS) NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol RBOT WS — thirty (30) whole warrants are exercisable to purchase one share of Class A common stock of Vicarious Surgical Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company's Class A common stock — tick. Business Wire 2025-12-16 16:00:00
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced its full-year 2026 cash burn guidance. Vicarious Surgical expects full-year 2026 cash burn of approximately $35 million, representing a $10 million improvement from the Company's recently updated 2025 guidance of $45 million. Cash needs beyond existing cash resources to achieve desi. Business Wire 2025-12-15 08:30:00
Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced an update to full-year 2025 financial guidance. Vicarious Surgical now expects full-year 2025 cash burn of approximately $45 million, representing a $5 million improvement from its previous guidance of $50 million. The improved guidance reflects disciplined cost management initiativ. Business Wire 2025-12-03 07:00:00

SEC Filings

Type Filing Date Accepted Date Link
4 2026-02-24 2026-02-24 View Filing
4 2026-02-24 2026-02-24 View Filing
8-K 2026-02-02 2026-02-02 View Filing
8-K 2026-01-09 2026-01-09 View Filing
EFFECT 2025-12-22 2025-12-23 View Filing
424B5 2025-12-22 2025-12-22 View Filing
25-NSE 2025-12-17 2025-12-17 View Filing
8-K 2025-12-16 2025-12-16 View Filing
DEF 14A 2025-12-16 2025-12-15 View Filing
S-3 2025-12-12 2025-12-12 View Filing
424B3 2025-12-09 2025-12-09 View Filing
EFFECT 2025-12-08 2025-12-09 View Filing
PRE 14A 2025-12-05 2025-12-05 View Filing
4 2025-12-04 2025-12-04 View Filing
4 2025-12-04 2025-12-04 View Filing
8-K 2025-12-03 2025-12-03 View Filing
4 2025-11-21 2025-11-21 View Filing
4 2025-11-21 2025-11-21 View Filing
S-3 2025-11-13 2025-11-12 View Filing
10-Q 2025-11-12 2025-11-12 View Filing
8-K 2025-11-12 2025-11-12 View Filing
D 2025-10-15 2025-10-15 View Filing
8-K 2025-10-08 2025-10-08 View Filing
424B5 2025-10-08 2025-10-08 View Filing
4 2025-10-02 2025-10-02 View Filing
3 2025-10-02 2025-10-02 View Filing
8-K 2025-09-25 2025-09-25 View Filing
8-K 2025-09-23 2025-09-23 View Filing
8-K 2025-09-16 2025-09-16 View Filing
8-K 2025-09-08 2025-09-08 View Filing
4 2025-09-04 2025-09-04 View Filing
4 2025-09-04 2025-09-04 View Filing
4 2025-08-27 2025-08-27 View Filing
4 2025-08-21 2025-08-21 View Filing
4 2025-08-21 2025-08-21 View Filing
4 2025-08-21 2025-08-21 View Filing
10-Q 2025-08-12 2025-08-12 View Filing
8-K 2025-08-12 2025-08-12 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
3 2025-08-11 2025-08-11 View Filing
3 2025-08-11 2025-08-11 View Filing
8-K 2025-07-31 2025-07-31 View Filing
8-K 2025-07-11 2025-07-11 View Filing
S-8 2025-07-02 2025-07-02 View Filing
8-K 2025-06-30 2025-06-30 View Filing
4 2025-06-24 2025-06-24 View Filing
4 2025-06-24 2025-06-24 View Filing
4 2025-06-04 2025-06-04 View Filing
4 2025-06-04 2025-06-04 View Filing
4 2025-05-21 2025-05-21 View Filing
4 2025-05-21 2025-05-21 View Filing
8-K 2025-05-13 2025-05-12 View Filing
10-Q 2025-05-12 2025-05-12 View Filing
ARS 2025-04-29 2025-04-29 View Filing
DEFA14A 2025-04-29 2025-04-29 View Filing
DEF 14A 2025-04-29 2025-04-29 View Filing
3 2025-04-11 2025-04-11 View Filing
4 2025-03-24 2025-03-24 View Filing
4 2025-03-24 2025-03-24 View Filing
8-K 2025-03-24 2025-03-24 View Filing
10-K 2025-03-17 2025-03-17 View Filing
8-K 2025-03-17 2025-03-17 View Filing
8-K 2025-03-13 2025-03-13 View Filing
4 2025-03-04 2025-03-04 View Filing
4 2025-03-04 2025-03-04 View Filing
4 2025-03-04 2025-03-04 View Filing
4 2025-02-21 2025-02-21 View Filing
4 2025-02-21 2025-02-21 View Filing
8-K 2025-02-18 2025-02-18 View Filing
8-K 2025-01-21 2025-01-21 View Filing
4 2024-12-26 2024-12-26 View Filing
4 2024-12-26 2024-12-26 View Filing
4 2024-12-26 2024-12-26 View Filing
8-K 2024-12-06 2024-12-06 View Filing
4 2024-12-04 2024-12-04 View Filing
4 2024-12-04 2024-12-04 View Filing
4 2024-12-04 2024-12-04 View Filing
4 2024-12-04 2024-12-04 View Filing
4 2024-11-21 2024-11-21 View Filing
4 2024-11-21 2024-11-21 View Filing
4 2024-11-21 2024-11-21 View Filing
10-Q 2024-11-12 2024-11-12 View Filing
8-K 2024-11-12 2024-11-12 View Filing
4 2024-09-23 2024-09-23 View Filing
4 2024-09-23 2024-09-23 View Filing
4 2024-09-23 2024-09-23 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-08-21 2024-08-21 View Filing
4 2024-08-21 2024-08-21 View Filing
4 2024-08-21 2024-08-21 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Heikin Ashi Strategy 21.01% 1.81 3 0.8 0.65 34.15
Liquidity Sweep Strategy 10.97% 1 6 0.34 0.52 24.11
Parabolic SAR Strategy 9.42% 0.99 39 0.23 0.1 22.55
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x x xxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx x xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% xxxx xx xxx xxxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxx xxxx x
xxxxxxxxxx xxxxxxx% xxxx xx xxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxx
xxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxx% x xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxx
xxxxxxxxx xxxxxxx% xxxx x xxxxx xxxxx xxx
xxxxxxxxxxxxxxxx xxxxxxx% x x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxxx
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% xxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxxx